NRX Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Good morning, everyone, and thank you for attending the H.C. Wainwright 24th Annual Global Investment Conference. My name is Sean Lee. I'm an equity research analyst at the bank. To this morning's presentation, I'd like to welcome Mr. Steve Willard, who is the Chief Executive Officer of NRx Pharmaceuticals.
Thank you very much, and we're delighted to be here at H.C. Wainwright and have the opportunity to present to people who are interested in what the exciting things that we do are to offer.
We offer -- first of all, a forward-looking statement. We are a public company, and it's important, and I will be making statements about the future that are covered within the Safe Harbor Act as set out in the presentation.
We bring hope to life. That's what we basically do. To try accomplish that is we take existing drugs, which have a demonstrated safety profile, and we find new methods of mechanisms of action or method of application to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |